Development and characterization of a patient‑derived orthotopic xenograft of therapy‑resistant breast cancer

Numerous years of cell line-based studies have enhanced the current understanding of cancer and its treatment. However, limited success has been achieved in treating hormone receptor-positive, HER2-negative metastatic breast cancers that are refractory to treatment. The majority of cancer cell lines...

Descripción completa

Detalles Bibliográficos
Autores principales: Butti, Ramesh, Kapse, Prachi, Bhadauriya, Garima, Ahmad, Suhail, Chaubal, Rohan, Parab, Pallavi, Kadam, Rasika, Mahapatra, Soumya S., Shet, Tanuja, Dutt, Amit, Gupta, Sudeep, Kundu, Gopal C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2023
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10091080/
https://www.ncbi.nlm.nih.gov/pubmed/36999625
http://dx.doi.org/10.3892/or.2023.8536

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10091080/
https://www.ncbi.nlm.nih.gov/pubmed/36999625
http://dx.doi.org/10.3892/or.2023.8536

Ejemplares similares